文章核心观点 - Aveanna Healthcare Holdings Inc（AVAH）在盘前发布了2026年第三季度财务业绩，公司在本年度每个季度均超出分析师预期 [1] - 公司认为金融市场是有效的，大多数股票反映了其真实的当前价值，个股最佳盈利机会往往来自普通投资者关注度较低的股票，或来自那些可能未准确反映其市场当前机遇的股票 [1] 公司业绩表现 - 公司在2026年第三季度再次超出分析师预期，且本年度每个季度均实现了对分析师预期的超越 [1] 行业与市场观点 - 金融市场具有有效性，大多数股票反映其真实当前价值 [1] - 个股利润的最佳机会通常来源于平均投资者关注度较低的股票 [1] - 个股利润机会也可能来自那些未能准确反映其市场现有机会的股票 [1]

For the quarter ended September 2026, Aveanna Healthcare (AVAH) reported revenue of $695.54 million, up 11.8% over the same period last year. EPS came in at $0.23, compared to $0.15 in the year-ago quarter.The reported revenue represents a surprise of +1.81% over the Zacks Consensus Estimate of $683.17 million. With the consensus EPS estimate being $0.20, the EPS surprise was +15%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall ...

Third Quarter Revenue was $695.5 million, an 11.8% increase over the prior year periodThird Quarter Net income was $45.5 million compared to $14.1 million for the prior year periodAdjusted EBITDA for Q3 2026 was $100.1 million, a 25.0% increase over the prior year periodIncreased Full Year 2026 Revenue guidance to greater than $2.695 billion, updated from greater than $2.68 billion Increased Full Year 2026 Adjusted EBITDA guidance to greater than $374 million, updated from greater than $365 million ATLANTA ...